{"chunk_id": "WHO_GUIDELINES(TRAIN DATA)__chunk_649", "source": "WHO_GUIDELINES(TRAIN DATA)", "text": "rimester of pregnancy compared \nwith no intervention or placebo (EB T able C.4)\nThe following evidence on the effects of prophylactic \nanthelminthic treatment was derived from a \nCochrane review that included four trials conducted \nin Peru, Sierra Leone and Uganda, involving 4265 \npregnant women (142). In two trials (Peru and Sierra \nLeone), the anthelminthic medication (albendazole \nor mebendazole) was administered as a single dose \nin the second trimester, with or without daily iron and \nfolic"}